参考文献/References:
[1] 朱钦士.什么是“表观遗传学”[J].生物学通报,2014,49(8):20-22.
[2] 王洁,张心怡.组蛋白去乙酰化酶抑制剂的研究进展[J].现代生物医学进展,2014,14(14):2783-2785.
[3] 潘雪莉,张爱华,黄晓欣,等.HDAC1在燃煤污染型砷中毒患者血液及皮肤组织中的转录及表达[J].环境与职业医学,2015,27(5):270-273.
[4] Ooi SK,Bestor TH.The colorful history of active DNA demathylation [J].Cell,2008,133(7):45-48.
[5] Yang X,Lay F,Han H,et al.Targeting DNA methylation for epigenetic therapy[J].Trends Pharmacol Sci,2010,31(11):536-546.
[6] 张玲,盛树力,秦川,等.表观遗传学药物的研究进展[J].中国药理学通报,2013,29(3):297-303.
[7] 苏玉文.寻常型银屑病外周血单个核细胞和皮损组织表观遗传修饰异常的研究[D].湖南:中南大学,2010.
[8] 李正风,王红梅,系统性红斑狼疮的表观遗传学发病机制[J].中国中西医结合皮肤性病学杂志,2015,14(2):130-133.
[9] Makino K,Jinnin M,Kajihara I,et al.Circulating miR-142-3p levels in patients with systemic sclerosis[J].Clin Exp Dermatol,2012,37(1):34-39.
[10] Honda N,Jinnin M,Kira-Etoh T,et al.miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin β3[J].Am J Pathol,2013,182(1):206-16.
[11] 罗鸯鸯.系统性硬皮病患者CD4+T细胞组蛋白修饰异常的研究[D].湖南:中南大学,2013.
[12] 王瑶瑶,系统性硬皮病患者CD4+T细胞表观遗传学修饰异常的研究[D].湖南:中南大学,2014.
[13] Bannister AJ,Kouzarides T.Regulation of chromatin by Histone modications[J].Cell Research,2011,21:381-395.
[14] Ando Y,Yang GX,Kenny TP,et al.Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-beta receptor type Ⅱ mouse[J].J Autoimmum,2013,41:111-119.
[15] Tang Y,Luo X,Cui H,et al.MicroRNA-146A contributes to abnormal Activation of the type I interferon pathway in human lupus by targeting the key signaling proteins[J].Arthritis Rheum, 2009,60(4):1065-1075.
[16] Herberth G,Bauer M,Gasch M,et al.Maternal and cord blood miR-223 expression associates with prenatal tobacco smoke exposure and low regulatory T-cell numbers[J].J Allergy Clin Immunol,2014,133(2):543-550.
[17] Almanza G,fernandez A,Volinia S,et al.Selected microRNAs define cell fate determination of murine central memory CD8 T cells[J].PLoS One, 2010,5(6):243.
[18] Dees C,Schlottmann I,Funke R,et al.The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethyla-tion in systemic sclerosis[J].AnnRheum Dis,2014,73(6):1232-1239.
[19] 郭瑜,陆前进.表观遗传调控与自身免疫性疾病治疗[J].中国免疫学杂志,2015,31(7): 865-873.
[20] Lee HS,Bae SC.What can we learn from genetic studies of systemic lupus erythematosus? Implications of genetic heterogeneity among populations in SLE[J].Lupus,2010, 19(12):1452-1459.
[21] Sestak AL,Fürnrohr BG,Harley JB,et al.The genetics of systemic lupus erythematosus and implications for targeted therapy[J].AnnRheum Dis,2011,70( Suppl 1):37-43.
[22] 杨阳.霉酚酸通过表观遗传学机制对系统性红斑狼疮患者CD4+T细胞自身免疫相关基因表达的影响[D].湖南:中南大学,2014.
[23] Zhao M, Wu X, Zhang Q, et al. RFX1 regulates CD70 and CD11a expression in T cells by recruiting the histone methyltrans ferase SUV39H1[J].Arthritis Res Ther,2010,12(6):R227.
[24] 彭元洪,钟晓武,青玉凤,等.DNA甲基化在风湿性疾病中的作用研究进展[J],医学综述,2016,22(18):3557-3560.
[25] Balada E,Castro-Marrero J,Felip L,et al.Associations betweenthe expression of epigenetically regulated genes and the expression of DNMTs and MBDs in systemic lupus erythematosus[J].PLoS One,2012,7(9):45897.
[26] Bird A,Molecular biology.Methylation talk between histones and DNA[J].Science,2001,294(5549):2113-2115.
[27] de la Rica L,Urquiza JM,Gomez-Cabrero D,et al.Identification of novel markers in rheumatoid arthritis through integrated analysis of DNA methylation and microRNA expression[J].J Autoimmun,2013,41:6-16.
[28] Dai Y,Sui W,Lan H,et al.Comprehensive analysis of microRNA expresion patterns in renal biopsies of Lupus nephritis patients[J].Rheumatol Int,2008,29(7):749-54.
[29] Dai R,McReynolds S,Leroith T,et al.Sex differences in the expression of Lupus-associated miRNAs in splenocytes from lupusprone NZB/WFI mice[J].Biol Sex Differ,2013,4(1):19.
[30] 朱小华,徐金华.SLE 患者 DNA 低甲基化对 DNMT1 启动子表观修饰负反馈调控的研究[J].中国免疫学杂志,2016,32(4):542-545,552.
[31] 姚承佼,钟晓武,黄翠平,等.DNA 甲基转移酶基因多态性与自身免疫性疾病关系的研究进展[J].山东医药,2016,56(4):91-94.